Publications by authors named "Alex Kanno Issamu"
Hum Vaccin Immunother
March 2020
Article Synopsis
- The research focused on improving tuberculosis vaccines, particularly a recombinant BCG vaccine called rBCG-LTAK63, which showed better protection in mice than the standard BCG vaccine.
- The study analyzed the immune responses generated by both vaccines, finding that rBCG-LTAK63 led to heightened levels of important immune cells like neutrophils and lymphocytes, along with increased production of key signaling molecules.
- Results indicated that rBCG-LTAK63 not only boosted short-term immune responses but also promoted a more robust long-term response, suggesting it could offer superior protection against tuberculosis compared to traditional BCG.*
